- Filed
- May 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 110.42M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 110.31M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 271.48M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$152.38K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$112.69K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $13.18M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $13.22M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $14.17M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $296.61K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.41M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.57M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $327.61K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $303.2K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $14.75M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $14.73M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income | Q1 2025 · Mar 31, 2025 | −$147.95K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$121.58K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$146.35K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$69.82K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $0 |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $27.92K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $36.92K |
| Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $64.84K |